Total words: 12497 | 2-word phrases: 3297 | 3-word phrases: 3904 | 4-word phrases: 4080
PAGE INFO
| Title | Try to keep the title under 60 characters (8 characters)
Alpha MD |
| Description | Try to keep the meta description between 50 - 160 characters (0 characters)
|
| Keywords | Meta keywords are not recommended anymore (0 characters)
|
| H1 | H1 tag on the page (18 characters)
HOW WE HELP PHARMA |
ONE WORD PHRASES 1216 Words
| # |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
| 1 | and | | | | | | | 204 | 16.78% |
| 2 | the | | | | | | | 133 | 10.94% |
| 3 | to | | | | | | | 122 | 10.03% |
| 4 | image | | | | | | | 70 | 5.76% |
| 5 | of | | | | | | | 65 | 5.35% |
| 6 | card | | | | | | | 65 | 5.35% |
| 7 | cap | | | | | | | 65 | 5.35% |
| 8 | we | | | | | | | 65 | 5.35% |
| 9 | health | | | | | | | 58 | 4.77% |
| 10 | in | | | | | | | 57 | 4.69% |
TWO WORD PHRASES 3297 Words
| # |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
| 1 | card image | | | | | | | 65 | 1.97% |
| 2 | image cap | | | | | | | 65 | 1.97% |
| 3 | alpha md | | | | | | | 31 | 0.94% |
| 4 | we are | | | | | | | 16 | 0.49% |
| 5 | are a | | | | | | | 15 | 0.45% |
| 6 | on a | | | | | | | 14 | 0.42% |
| 7 | is a | | | | | | | 14 | 0.42% |
| 8 | and the | | | | | | | 13 | 0.39% |
| 9 | clinical trial | | | | | | | 13 | 0.39% |
| 10 | out the | | | | | | | 11 | 0.33% |
| 11 | in the | | | | | | | 11 | 0.33% |
| 12 | md edu | | | | | | | 10 | 0.30% |
| 13 | about the | | | | | | | 10 | 0.30% |
| 14 | with the | | | | | | | 9 | 0.27% |
| 15 | clinical trials | | | | | | | 9 | 0.27% |
| 16 | are and | | | | | | | 9 | 0.27% |
| 17 | of the | | | | | | | 9 | 0.27% |
| 18 | md health | | | | | | | 9 | 0.27% |
| 19 | to a | | | | | | | 8 | 0.24% |
| 20 | care and | | | | | | | 8 | 0.24% |
THREE WORD PHRASES 3904 Words
| # |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
| 1 | card image cap | | | | | | | 65 | 1.66% |
| 2 | alpha md edu | | | | | | | 10 | 0.26% |
| 3 | alpha md health | | | | | | | 9 | 0.23% |
| 4 | alpha md pro | | | | | | | 5 | 0.13% |
| 5 | how we help | | | | | | | 5 | 0.13% |
| 6 | we help pharma | | | | | | | 4 | 0.10% |
| 7 | are committed to | | | | | | | 4 | 0.10% |
| 8 | we are committed | | | | | | | 4 | 0.10% |
| 9 | for case study | | | | | | | 3 | 0.08% |
| 10 | we are here | | | | | | | 3 | 0.08% |
| 11 | their health and | | | | | | | 3 | 0.08% |
| 12 | are here to | | | | | | | 3 | 0.08% |
| 13 | manage their health | | | | | | | 3 | 0.08% |
| 14 | md edu can | | | | | | | 3 | 0.08% |
| 15 | of new drugs | | | | | | | 3 | 0.08% |
| 16 | ask for case | | | | | | | 3 | 0.08% |
| 17 | platform can offer | | | | | | | 2 | 0.05% |
| 18 | designed to help | | | | | | | 2 | 0.05% |
| 19 | data rwd and | | | | | | | 2 | 0.05% |
| 20 | innovative solutions that | | | | | | | 2 | 0.05% |
| 21 | we have a | | | | | | | 2 | 0.05% |
| 22 | public health specialist | | | | | | | 2 | 0.05% |
| 23 | public health literacy | | | | | | | 2 | 0.05% |
| 24 | an oidpm assessment | | | | | | | 2 | 0.05% |
| 25 | diverse backgrounds and | | | | | | | 2 | 0.05% |
| 26 | highest standards of | | | | | | | 2 | 0.05% |
| 27 | of pharmaceutical products | | | | | | | 2 | 0.05% |
| 28 | the healthcare space? | | | | | | | 2 | 0.05% |
| 29 | post discharge education | | | | | | | 2 | 0.05% |
| 30 | product life cycle | | | | | | | 2 | 0.05% |
FOUR WORD PHRASES 4080 Words
| # |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
| 1 | we are committed to | | | | | | | 4 | 0.10% |
| 2 | we are here to | | | | | | | 3 | 0.07% |
| 3 | ask for case study | | | | | | | 3 | 0.07% |
| 4 | alpha md edu can | | | | | | | 3 | 0.07% |
| 5 | how we help pharma | | | | | | | 3 | 0.07% |
| 6 | world data rwd and | | | | | | | 2 | 0.05% |
| 7 | patients alpha md edu | | | | | | | 2 | 0.05% |
| 8 | alpha md health is | | | | | | | 2 | 0.05% |
| 9 | data rwd and real | | | | | | | 2 | 0.05% |
| 10 | their health and care | | | | | | | 2 | 0.05% |
| 11 | md health is designed | | | | | | | 2 | 0.05% |
| 12 | health is designed to | | | | | | | 2 | 0.05% |
| 13 | orcha india data protection | | | | | | | 2 | 0.05% |
| 14 | conditions treatment options and | | | | | | | 2 | 0.05% |
| 15 | biostatisticians public health specialist | | | | | | | 2 | 0.05% |
| 16 | the highest standards of | | | | | | | 2 | 0.05% |
| 17 | using real world data | | | | | | | 2 | 0.05% |
| 18 | our goal is to | | | | | | | 2 | 0.05% |
| 19 | to create a world | | | | | | | 2 | 0.05% |
| 20 | md edu offers a | | | | | | | 2 | 0.05% |
| 21 | and real world evidence | | | | | | | 2 | 0.05% |
| 22 | drugs and medical devices | | | | | | | 2 | 0.05% |
| 23 | new drugs and medical | | | | | | | 2 | 0.05% |
| 24 | of new drugs and | | | | | | | 2 | 0.05% |
| 25 | with data protection norms | | | | | | | 2 | 0.05% |
| 26 | in areas such as | | | | | | | 2 | 0.05% |
| 27 | customised decks or videos | | | | | | | 2 | 0.05% |
| 28 | about their products and | | | | | | | 2 | 0.05% |
| 29 | alpha md edu offers | | | | | | | 2 | 0.05% |
| 30 | manage their health and | | | | | | | 2 | 0.05% |
| 31 | dpdpa oidpm will help | | | | | | | 1 | 0.02% |
| 32 | indian dpdpa oidpm will | | | | | | | 1 | 0.02% |
| 33 | own indian dpdpa oidpm | | | | | | | 1 | 0.02% |
| 34 | and our very own | | | | | | | 1 | 0.02% |
| 35 | our very own indian | | | | | | | 1 | 0.02% |
| 36 | very own indian dpdpa | | | | | | | 1 | 0.02% |
| 37 | you to identify those | | | | | | | 1 | 0.02% |
| 38 | if we use the | | | | | | | 1 | 0.02% |
| 39 | to identify those gaps | | | | | | | 1 | 0.02% |
| 40 | identify those gaps and | | | | | | | 1 | 0.02% |
EXTERNAL LINKS